Ronald Reed, MD | |
420 S 5th Ave, West Reading, PA 19611 | |
(484) 628-3637 | |
Not Available |
Full Name | Ronald Reed |
---|---|
Gender | Male |
Speciality | Emergency Medicine |
Location | 420 S 5th Ave, West Reading, Pennsylvania |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1346290483 | NPI | - | NPPES |
000645785 | Medicaid | PA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207P00000X | Emergency Medicine | MD014550E (Pennsylvania) | Primary |
Entity Name | Tower Health Medical Group |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1609291350 PECOS PAC ID: 7618889213 Enrollment ID: O20040311000072 |
News Archive
Protox Therapeutics Inc., a leader in the development of receptor targeted therapeutic fusion proteins, today released financial results for the third quarter, ended September 30, 2010.
BAC BV, the leading provider of antibody-based affinity purification technology, has extended its collaboration with GE Healthcare with the addition of a new bioprocess affinity chromatography ligand to GE Healthcare's range of custom designed media. The latest addition to the range is an affinity resin for the purification of alpha-1 antitrypsin (AAT) from blood plasma, recombinant cell culture or transgenic sources. The new resin has been developed as part of GE Healthcare's Custom Designed Media (CDM) programme and provides a new solution for AAT purification in the biopharmaceutical industry.
Vision deterioration in astronauts who spend a long time in space is likely due to the lack of a day-night cycle in intracranial pressure. But using a vacuum device to lower pressure for part of each day might prevent the problem, UT Southwestern Medical Center researchers said. Their study appears in the Journal of Physiology.
Aeterna Zentaris Inc. today announced that perifosine, its oral AKT inhibitor, combined with temsirolimus ("TEM"), was well tolerated in an investigator driven Phase 1 clinical trial in recurrent or progressive malignant glioma ("MG").
› Verified 7 days ago
Entity Name | Reading Hospital |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1992387518 PECOS PAC ID: 7618886490 Enrollment ID: O20040408001076 |
News Archive
Protox Therapeutics Inc., a leader in the development of receptor targeted therapeutic fusion proteins, today released financial results for the third quarter, ended September 30, 2010.
BAC BV, the leading provider of antibody-based affinity purification technology, has extended its collaboration with GE Healthcare with the addition of a new bioprocess affinity chromatography ligand to GE Healthcare's range of custom designed media. The latest addition to the range is an affinity resin for the purification of alpha-1 antitrypsin (AAT) from blood plasma, recombinant cell culture or transgenic sources. The new resin has been developed as part of GE Healthcare's Custom Designed Media (CDM) programme and provides a new solution for AAT purification in the biopharmaceutical industry.
Vision deterioration in astronauts who spend a long time in space is likely due to the lack of a day-night cycle in intracranial pressure. But using a vacuum device to lower pressure for part of each day might prevent the problem, UT Southwestern Medical Center researchers said. Their study appears in the Journal of Physiology.
Aeterna Zentaris Inc. today announced that perifosine, its oral AKT inhibitor, combined with temsirolimus ("TEM"), was well tolerated in an investigator driven Phase 1 clinical trial in recurrent or progressive malignant glioma ("MG").
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Ronald Reed, MD Po Box 13579, Reading, PA 19612-3579 Ph: (484) 628-0799 | Ronald Reed, MD 420 S 5th Ave, West Reading, PA 19611 Ph: (484) 628-3637 |
News Archive
Protox Therapeutics Inc., a leader in the development of receptor targeted therapeutic fusion proteins, today released financial results for the third quarter, ended September 30, 2010.
BAC BV, the leading provider of antibody-based affinity purification technology, has extended its collaboration with GE Healthcare with the addition of a new bioprocess affinity chromatography ligand to GE Healthcare's range of custom designed media. The latest addition to the range is an affinity resin for the purification of alpha-1 antitrypsin (AAT) from blood plasma, recombinant cell culture or transgenic sources. The new resin has been developed as part of GE Healthcare's Custom Designed Media (CDM) programme and provides a new solution for AAT purification in the biopharmaceutical industry.
Vision deterioration in astronauts who spend a long time in space is likely due to the lack of a day-night cycle in intracranial pressure. But using a vacuum device to lower pressure for part of each day might prevent the problem, UT Southwestern Medical Center researchers said. Their study appears in the Journal of Physiology.
Aeterna Zentaris Inc. today announced that perifosine, its oral AKT inhibitor, combined with temsirolimus ("TEM"), was well tolerated in an investigator driven Phase 1 clinical trial in recurrent or progressive malignant glioma ("MG").
› Verified 7 days ago
Liza Gergenti, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 420 S 5th Ave, West Reading, PA 19611 Phone: 484-628-3528 | |
Joshua Adam Werner, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 420 S 5th Ave, West Reading, PA 19611 Phone: 484-628-3637 | |
Eric Smith, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 420 S 5th Ave, West Reading, PA 19611 Phone: 484-628-8000 | |
James Sullivan, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 420 S 5th Ave, West Reading, PA 19611 Phone: 484-628-8000 | |
Ray Morganti, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 6th Ave & Spruce St, West Reading, PA 19611 Phone: 610-988-8218 | |
Dr. Joseph Patrick Corcoran Iv, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 420 S 5th Ave, West Reading, PA 19611 Phone: 484-628-8000 | |
Memu-iye Kamara, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 420 S 5th Ave, West Reading, PA 19611 Phone: 484-628-8000 |